Get the Stockscreener App
2.06
0.48%
-0.010
After Hours:
2.09
0.03
+1.46%
Compugen Ltd stock is traded at $2.06, with a volume of 119.73K.
It is down -0.48% in the last 24 hours and up +17.05% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
See More
Previous Close:
$2.07
Open:
$2.09
24h Volume:
119.73K
Relative Volume:
0.32
Market Cap:
$194.78M
Revenue:
$72.76M
Net Income/Loss:
$35.34M
P/E Ratio:
5.5781
EPS:
0.3693
Net Cash Flow:
$-62.91M
1W Performance:
-5.07%
1M Performance:
+17.05%
6M Performance:
+49.28%
1Y Performance:
+31.21%
1-Day Range:
$2.06
$2.165
1-Week Range:
$2.05
$2.165
52-Week Range:
$1.13
$2.38
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.06 | 195.73M | 72.76M | 35.34M | -62.91M | 0.3693 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-26 | Initiated | H.C. Wainwright | Buy |
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
RSI Check: Does Compugen Ltd meet Warren Buffetts criteria2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
If You Invested $1,000 in Compugen (CGEN) - Stock Titan
Aug Highlights: Is Compugen Ltd stock forming a triangle pattern2026 Performance Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Retail Trends: Will Compugen Ltd outperform the market in YEARWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 earnings call transcript - MSN
Compugen shares jump nearly 5% after strong Q4 earnings beat - MSN
Compugen (CGEN) director discloses initial share and option holdings - Stock Titan
CGEN (COMPUGEN LTD) CFO David Silberman discloses initial share and option holdings - Stock Titan
Compugen (CGEN) director discloses initial shares, RSUs and option grants - Stock Titan
Compugen (CGEN) director Eran Perry details shares, RSUs and options - Stock Titan
Compugen (CGEN) CEO Ophir Eran details share and long-dated option holdings - Stock Titan
Compugen (CGEN) CMO Michelle Mahler details option and RSU holdings - Stock Titan
[Form 3] COMPUGEN LTD Initial Statement of Beneficial Ownership - Stock Titan
Compugen (CGEN) director Mathias Hukkelhoven details initial equity holdings - Stock Titan
Compugen (CGEN) director Holcomb reports shares, options and RSUs - Stock Titan
Halevy Gilead discloses initial Compugen (CGEN) share and option holdings - Stock Titan
Compugen (CGEN) COO discloses 400,000 share options in Form 3 - Stock Titan
Compugen (CGEN) director Anat Cohen-Dayag reports initial share and option holdings - Stock Titan
Compugen (CGEN) SVP reports RSU and option stakes in Form 3 filing - Stock Titan
Sectors Review: What is the cash position of Compugen Ltd2026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn
Movement Recap: Whats the analyst consensus on Compugen LtdWeekly Risk Report & AI Forecasted Stock Moves - baoquankhu1.vn
Compugen Ltd. (CGEN) reports Q4 revenue of $67.3 million vs. $1.5 million last year - MSN
Institution Moves: How is Compugen Ltd managing supply chain issuesQuarterly Earnings Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year - Insider Monkey
Compugen (CGEN) Q4 2025 Earnings Call Transcript - AOL.com
Compugen at Leerink Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Australia
Compugen at Leerink Global Healthcare Conference: Strategic Insights - Investing.com South Africa
Short Squeeze: Is Compugen Ltd stock forming a triangle pattern2026 PreEarnings & Consistent Growth Stock Picks - baoquankhu1.vn
CGEN Earnings History & Surprises | EPS & Revenue Results | COMPUGEN LTD (NASDAQ:CGEN) - ChartMill
Q1 Earnings Estimate for Compugen Issued By HC Wainwright - Defense World
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - AOL.com
Compugen Q4 Earnings Call Highlights - Defense World
Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Compugen (CGEN) Quarterly Loss Near US$7 Million Tests Bullish Profitability Narrative - simplywall.st
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer - AOL.com
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Compugen earnings beat by $0.68, revenue topped estimates - Investing.com South Africa
Chegg Earnings: Big Quarter Sends Shares Higher - AOL.com
Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement (CGEN) - Seeking Alpha
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Compugen Q4 2025 Earnings Call Transcript - MarketBeat
Compugen Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
What Smart Money Loves About Lilly - AOL.com
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com
Earnings call transcript: Compugen Q4 2025 sees earnings beat, stock surges - Investing.com
CGEN: 2025 saw a cash runway extension, profitability, and global clinical trial progress - TradingView
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):